Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Speciality: Hematology
Description:
Heparin-induced thrombocytopenia, or HIT, is a serious complication that can occur when patients receive heparin, a common blood thinner. HIT happens when the immune system reacts to heparin, leading to a drop in platelet count and an increased risk of dangerous blood clots. Recent advances in medical technology now allow us to monitor platelet activation signatures – unique patterns that show how platelets respond to heparin in real time. By closely observing these signatures, clinicians can identify HIT earlier and adjust treatment before complications develop. This proactive approach not only improves patient safety but also helps personalise therapy, reducing the risk of severe outcomes. Monitoring platelet activation is a promising step forward in preventing HIT-related complications.
See More Webinars @ Hidoc Webinars
1.
tobacco use, the severity of their symptoms, and their desire to give up smoking among cancer survivors.
2.
Papillary thyroid cancer: New markers offer hope for tailored treatment
3.
Since 2000, the outlook for multiple myeloma has improved.
4.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
5.
T-DXd Reduces Residual Disease in Early Breast Cancer
1.
Developmental Changes in Pediatric Coagulation Networks
2.
Endurance Training in Hematologic Disease: Current Perspectives and Clinical Implications
3.
Beyond the Battle: Navigating Life After Cancer
4.
Decoding Hamartomas: Understanding Their Causes and Symptoms
5.
The Journey Beyond Treatment: Empowering Cancer Survivorship with Technology and Artificial Intelligence
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Prevention of Heparin-Induced Thrombocytopenia Complications Through Platelet Activation Signature Monitoring
2.
Navigating the Complexities of Ph Negative ALL - Part XVI
3.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
4.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
5.
Navigating the Complexities of Ph Negative ALL - Part IX
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge